| On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Special Announcements Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries The National Institute of Mental Health (NIMH) seeks to fund implementation research projects focused on the integrating mental health services with chronic health care across various healthcare and non-healthcare settings in low and middle-income countries (LMICs). The objective is to develop, refine, and evaluate innovative strategies to facilitate the integration of mental health care with other services. Application due date: February 5, 2025 Read funding opportunity (PAR-25-201) Global Perspectives on Climate Change and Humanitarian Health: Whatâs happening in the research space? As part of The Global Forum on Humanitarian Health Research (GFH2R) join us for an upcoming webinar hosted by Elrha and the Fogarty International Center, in collaboration with Canada's International Development Research Centre, focused on humanitarian health research in the context of climate change. Learn more about GFH2R 2025 Register for webinars Webinar Date: November 21, 2024 at 9 a.m. ET (USA) / 2 p.m. GMT (UK) Supplement for Capacity Building related to Bioethics Research NIH Office of Science Policy (OSP) is offering administrative supplements for research focused on bioethical issues, aiming to support evidence-based policy development and to build bioethics research capacity. This funding targets projects that examine ethical challenges linked to NIH priorities, such as public health crises, emerging technologies, and patient data use. The initiative encourages projects exploring patient data sharing, real-world data ethics, and patient engagement strategies, along with topics on bioethics education and diversity in innovation. Application due date: November 29, 2024 Read notice of special interest (NOT-OD-25-015) Date extended! Apply to be Fogarty's next Director, Division of International Training and Research The John E. Fogarty International Center of the National Institutes of Health (NIH) is seeking exceptional candidates with an MD, PhD or equivalent doctoral in biomedical science and senior-level research and research administration experience in one or more scientific areas related to global health for the position of Director of the Division of International Training and Research. Open to U.S. citizens, legal permanent residents, and non-U.S. citizens eligible for a valid work authorization. Applications due date extended to: November 24, 2024 Details and how to apply Upcoming Deadlines for Fogarty Funding Opportunities
Global Brain Disorders Research
Application deadline: November 15, 2024 Emerging Global Leader Award
Application deadline: December 3, 2024 HIV-associated Noncommunicable Diseases Research at LMIC Institutions
Application deadline: December 9, 2024 Funding opportunities on which Fogarty is a partner: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
Application due date: Multiple dates, see announcement. Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
Application due date: Multiple dates, see announcement. Administrative supplements for current Fogarty grant recipients: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)Â (NOT-OD-25-015)Â
Expiration date: January 24, 2025 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)Â (PA-20-272)Â
Expiration date: January 24, 2025 Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032)Â
Expiration date: October 1, 2025 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)Â (PA-23-189)Â
Expiration date: May 8, 2026 Funding Opportunities NIH funding opportunities focusing on global health and foreign collaboration: Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)Â (RFA-AG-25-031)
Application due date: Multiple dates, see announcement. Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)Â (RFA-AG-25-032)
Application due date: Multiple dates, see announcement. NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs funding opportunities: R01 Clinical Trial Not Allowed (PAR-25-107)
Application due date: February 5, 2025 R21 Clinical Trial Not Allowed (PAR-25-108)
Application due date: February 16, 2025 Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)Â (RFA-DA-26-024)
Application due date: February 27, 2025 Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)Â (PAR-25-186)
Application due date: February 28, 2025 Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) (P01 Clinical Trial Not Allowed)Â (RFA-AI-24-074)
Application due date: March 26, 2025 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)Â (PA-25-172)
Application due date: Multiple dates, see announcement. Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)Â (PA-25-253)
Application due date: Multiple dates, see announcement. Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)Â (PAR-24-306)
Application due date: Multiple dates, see announcement. Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)Â (PAR-24-325)
Application due date: Multiple dates, see announcement. Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)Â (PAR-25-036)
Application due date: Multiple dates, see announcement. NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)Â (PAR-25-049)
Application due date: Multiple dates, see announcement. Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)Â (PAR-25-063)
Application due date: Multiple dates, see announcement. Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)Â (PAR-25-079)
Application due date: Multiple dates, see announcement. Co-infection and Cancer funding opportunities: R01 Clinical Trial Not Allowed (PAR-25-082)
Application due date: Multiple dates, see announcement. R21 Clinical Trial Not Allowed (PAR-25-083)
Application due date: Multiple dates, see announcement. Cancer Prevention and Control Clinical Trials Planning Grant Program funding opportunities: U34 Clinical Trials Optional (PAR-25-103)
Application due date: Multiple dates, see announcement. R34 Clinical Trials Optional (PAR-25-104)
Application due date: Multiple dates, see announcement. Laboratories to Optimize Digital Health (R01 Clinical Trial Required)Â (PAR-25-136)
Application due date: Multiple dates, see announcement. NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)Â (PAR-25-139)
Application due date: Multiple dates, see announcement. In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)Â (PAR-25-140)
Application due date: Multiple dates, see announcement. Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)Â (PAR-25-145)
Application due date: Multiple dates, see announcement. Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)Â (PAR-25-146)
Application due date: Multiple dates, see announcement. Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)Â (PAR-25-153)
Application due date: Multiple dates, see announcement. Engineering Next-Generation Human Nervous System Microphysiological Systems funding opportunities R01 Clinical Trials Not Allowed (PAR-25-198)
Application due date: Multiple dates, see announcement. R21 Clinical Trials Not Allowed (PAR-25-199)
Application due date: Multiple dates, see announcement. Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)Â (PAR-25-221)
Application due date: Multiple dates, see announcement. NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)Â (PAR-25-222)
Application due date: Multiple dates, see announcement. Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)Â (PAR-25-225)
Application due date: Multiple dates, see announcement. Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)Â (PAR-25-227)
Application due date: Multiple dates, see announcement. NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)Â (PAR-25-234)
Application due date: Multiple dates, see announcement. Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)Â (PAR-25-237)
Application due date: Multiple dates, see announcement. NIH funding opportunities for which foreign components may apply: Limited Competition: Continued Development of INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed)Â (RFA-OD-25-002)
Application due date: December 12, 2024 Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)Â (PAR-24-311)
Application due date: Multiple dates, see announcement. NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)Â (PAR-25-027)
Application due date: Multiple dates, see announcement. Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)Â (PAR-25-106)
Application due date: Multiple dates, see announcement. Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)Â (PAR-25-117)
Application due date: Multiple dates, see announcement. Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)Â (PAR-25-175)
Application due date: Multiple dates, see announcement. Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)Â (PAR-25-218)
Application due date: Multiple dates, see announcement. Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)Â (PAR-25-219)
Application due date: Multiple dates, see announcement. Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)Â (PAS-25-190)
Application due date: Multiple dates, see announcement. Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)Â (PAS-25-205)
Application due date: Multiple dates, see announcement. BRAIN Initiative funding opportunities: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)Â (RFA-NS-25-021)
Application due date: Multiple dates, see announcement. Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)Â (RFA-NS-25-022)
Application due date: Multiple dates, see announcement. Other Funding News General NIH notices: Pre-Application Webinar for NOT-CA-25-004, Notice of Special Interest (NOSI): Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control (NOT-CA-25-008) Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-26-100, "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)" (NOT-MH-25-060) Notices of changes to NIH funding opportunities: Notice of Early Expiration of PAR-23-081, "Early and Late Stage Clinical Trials for the Spectrum of Alzheimerâs Disease/Alzheimerâs Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)" (NOT-AG-24-076) Notice of Change to Application Due Date and Clarification of Application Types Allowed for RFA-DK-25-024 "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)" (NOT-DK-25-005) NIH Notices of Special Interest (NOSIs): Notice of Competitive Revision to Expand Recruitment in Ongoing NHLBI-Funded Cohort Studies (NOT-HL-24-029)
Expiration date: December 17, 2024 Administrative Supplements to Support Vanguard Study for CSRN Investigators (NOT-CA-24-111)
Expiration date: January 30, 2025 Non-NIH funding opportunities: The American Institute of Indian Studies is accepting applications for a variety of fellowships providing funding to pre- and post-doctoral scholars in pursuit of knowledge about India.
Application deadline: November 15, 2024 The American Association of University Women (AAUW) is accepting applications for International Fellowships. Fellowships are awarded for full-time study or research in the United States to women who are not U.S. citizens or permanent residents.
Application deadline: November 15, 2024 The Wellcome career development awards provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.
Application deadline: November 26, 2024 The Make Our Planet Great Again (MOPGA) initiative are seeking at least 60 early career researchers wishing to carry out their research in France. Eligible research themes include: Earth systems, Climate change and sustainability, energy transition, Societal challenges of environmental issues and Human, animal and ecosystem health as part as a "One Health" approach.
Application deadline: December 5, 2024 Featured News and Information Fogarty News Reframing the mental health stressors of Syrian refugees
Global Health Matters, September/October 2024 NIH News NIH trial of rectal microbicide for HIV prevention begins in the United States
NIH News, October 31, 2024 Training Opportunities Two-Part Virtual Event, NIH Grants Process Primer: Application to Award NIH is hosting a two-part event that will provide participants with the basics to help you in your role working with the NIH grants process from application preparation to award. In Part One NIH experts will introduce participants to the NIH as an organization, key components of finding the right funding opportunity, the NIH team, application, and more. In Part Two participants will have the opportunity to view demos and engage during this next-level look at tools and systems used during the application process. Virtual event dates: November 13-14, 2024 at 1:00-4:00 pm ET Register RSSE Africa To Discuss Open Science and Coding in Research RSSE Africa has partnered with RSE Asia to run a six-part virtual community conversation series focusing on open science and coding in research. The second episode will focus specifically on Enabling Reproducibility through Research Code. Webinar date: November 14, 2024 at 3:30 a.m. ET Register Now  Cornell Accepting Applications for Global Womenâs Health Training Applications are now open for the Global Infectious Diseases across a Woman's Lifespan Course, and the Womenâs Infectious Diseases in Global Health Scholars (WINGS) Program . Applications due: January 31, 2025 Apply here Manuscript, Abstract & Poster Submission Opportunities The Pan African Medical Journal is welcoming papers for a special edition related to all aspects of mpox in Africa, including epidemiology, research, clinical practice, outbreak investigation and response, and other relevant mpox data and activities in Africa. Submissions due: November 30, 2024 The Research for Health in Humanitarian Crises (R2HC) Forum will be a 3-day event, held in Nairobi, Kenya between 7-9 May 2025, and co-hosted with the African Population Health Research Center (APHRC). Elrha is inviting humanitarian health research, policy, and practice experts, with experience relevant to the key objectives and themes of the Forum, to contribute to making it a stimulating, engaging, and inclusive event. Submissions due: December 15, 2024 The International Cancer Screening Network (ICSN) is now accepting abstract submissions for ICSN 2025, which will be held June 18-20, 2025 in Aarhus, Denmark. The theme of ICSN 2025 is "Shaping the Future of Cancer Screening." Submitters are encouraged to submit abstracts that explore topics relating to one of the 10 abstracts themes. Submissions due: January 2, 2025 The National Cancel Institute is now accepting presentations on topics related to global cancer research and control to submit a scientific abstract and/or scientific session proposal. Submissions due: January 17, 2025 The Abstract Submission portal for INTEREST 2025, being held May 13-16, 2025, in Windhoek, Namibia, is now open. Successful candidates will be invited for an oral, mini-oral, or poster presentation. Submissions due: January 17, 2025 Events Events for global health researchers: Fogarty International Center Strategic Planning Listening Session Date: November 13 Location: New Orleans, LA Listening session led by Dr. Peter Kilmarx Part of the ASTMH 2024 Annual Meeting Women, Power, and Cancer @ London Global Cancer Week 2024 Date: November 13 Location: Virtual Hosted by the National Cancer Institute Center for Global Health NIH Grants Process Primer: Application to Award - Part One Date: November 13 Location: Virtual Hosted by the NIH Office of Extramural Research NIH Grants Process Primer: Application to Award - Part Two Date: November 14 Location: Virtual Hosted by the NIH Office of Extramural Research Power of Partnerships: The Role of the US Government in Advancing Global Health  Date: November 14 Location: New Orleans, LA and virtual Part of the ASTMH 2024 Annual Meeting Tobacco Control in Armenia and Georgia â Research Assessing Strategies for Community Mobilization and Intervention Dissemination Date: November 14 Location: Virtual Part of the National Cancer Instituteâs Global Cancer Research and Control Seminar Series DS-I Africa Consortium Meeting  Date: November 16â22 Location: Mauritius Global Food Security: Research to Inform Evidence-based Policies and Practices Date: November 18, 2024 Location: Virtual Hosted by the NIH Office of Disease Prevention Global Symposium on Health Systems Research Date: November 18â22 Location: Nagasaki, Japan Hosted by Health Systems Global Assailed at Home; Champions Abroad: The ACNMâs Push for Maternal Healthcareâ¯Advancementsâ¯in Nigeria Date: November 21, 2024 Location: Virtual Hosted by the National Library of Medicine |
